Showing results (941-950 of 960) with videos related to

Sort By:
Pageof 96
Cancer Immunology, Immunotherapy : CII|August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunityAurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Nature|February 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Cancer Research|February 9, 2024
Single-Cell Analysis Identifies NOTCH3-Mediated Interactions between Stromal Cells That Promote Microenvironment Remodeling and Invasion in Lung AdenocarcinomaHandan Xiang, Yidan Pan, Marc A Sze, et al.
Nature|February 28, 2020
Peripheral T cell expansion predicts tumour infiltration and clinical responseThomas D Wu, Shravan Madireddi, Patricia E de Almeida, et al.
The Journal of Clinical Investigation|October 23, 2025
The hematopoietic stem cell MYB enhancer is essential for and recurrently amplified during T cell leukemogenesisCarea Mullin, Karena Lin, Elizabeth Choe, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 25, 2022
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countriesM Stolbrink, M J Chinouya, S Jayasooriya, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Microbiome|June 9, 2021
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Blood|March 18, 2025
STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALLJason Xu, Jonathan H Sussman, Austin Yang, et al.
Pageof 96